United States Biosimilar Market Report 2018

United States Biosimilar Market Report 2018

1 Biosimilar Overview

1.1 Product Overview and Scope of Biosimilar

1.2 Classification of Biosimilar by Product Category

1.2.1 United States Biosimilar Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 Antibody

1.2.4 Hormone

1.2.5 Growth Factors

1.2.6 Other

1.3 United States Biosimilar Market by Application/End Users

1.3.1 United States Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 United States Biosimilar Market by Region

1.4.1 United States Biosimilar Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Biosimilar Status and Prospect (2013-2025)

1.4.3 Southwest Biosimilar Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Biosimilar Status and Prospect (2013-2025)

1.4.5 New England Biosimilar Status and Prospect (2013-2025)

1.4.6 The South Biosimilar Status and Prospect (2013-2025)

1.4.7 The Midwest Biosimilar Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Biosimilar (2013-2025)

1.5.1 United States Biosimilar Sales and Growth Rate (2013-2025)

1.5.2 United States Biosimilar Revenue and Growth Rate (2013-2025)

2 United States Biosimilar Market Competition by Players/Suppliers

2.1 United States Biosimilar Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Biosimilar Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Biosimilar Average Price by Players/Suppliers (2013-2018)

2.4 United States Biosimilar Market Competitive Situation and Trends

2.4.1 United States Biosimilar Market Concentration Rate

2.4.2 United States Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

3 United States Biosimilar Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Biosimilar Sales and Market Share by Region (2013-2018)

3.2 United States Biosimilar Revenue and Market Share by Region (2013-2018)

3.3 United States Biosimilar Price by Region (2013-2018)

4 United States Biosimilar Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States Biosimilar Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States Biosimilar Revenue and Market Share by Type (2013-2018)

4.3 United States Biosimilar Price by Type (2013-2018)

4.4 United States Biosimilar Sales Growth Rate by Type (2013-2018)

5 United States Biosimilar Sales (Volume) by Application (2013-2018)

5.1 United States Biosimilar Sales and Market Share by Application (2013-2018)

5.2 United States Biosimilar Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States Biosimilar Players/Suppliers Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Biosimilar Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Roche

6.2.2 Biosimilar Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Roche Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Eli Lilly

6.3.2 Biosimilar Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Eli Lilly Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Bayer

6.4.2 Biosimilar Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Bayer Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Amgen

6.5.2 Biosimilar Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Amgen Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Sanofi-Aventis

6.6.2 Biosimilar Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Sanofi-Aventis Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Johnson & Johnson

6.7.2 Biosimilar Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Johnson & Johnson Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Novo Nordisk

6.8.2 Biosimilar Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Novo Nordisk Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Merck

6.9.2 Biosimilar Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Merck Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

7 Biosimilar Manufacturing Cost Analysis

7.1 Biosimilar Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Biosimilar

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Biosimilar Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Biosimilar Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Biosimilar Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States Biosimilar Sales Volume, Revenue Forecast (2018-2025)

11.2 United States Biosimilar Sales Volume Forecast by Type (2018-2025)

11.3 United States Biosimilar Sales Volume Forecast by Application (2018-2025)

11.4 United States Biosimilar Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Biosimilar

Figure United States Biosimilar Market Size (K Units) by Type (2013-2025)

Figure United States Biosimilar Sales Volume Market Share by Type (Product Category) in 2017

Figure Antibody Product Picture

Figure Hormone Product Picture

Figure Growth Factors Product Picture

Figure Other Product Picture

Figure United States Biosimilar Market Size (K Units) by Application (2013-2025)

Figure United States Sales Market Share of Biosimilar by Application in 2017

Figure Tumor Examples

Table Key Downstream Customer in Tumor

Figure Diabetes Examples

Table Key Downstream Customer in Diabetes

Figure Cardiovascular Examples

Table Key Downstream Customer in Cardiovascular

Figure Hemophilia Examples

Table Key Downstream Customer in Hemophilia

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Biosimilar Market Size (Million USD) by Region (2013-2025)

Figure The West Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Biosimilar Sales (K Units) and Growth Rate (2013-2025)

Figure United States Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Biosimilar Market Major Players Product Sales Volume (K Units) (2013-2018)

Table United States Biosimilar Sales (K Units) of Key Players/Suppliers (2013-2018)

Table United States Biosimilar Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Biosimilar Sales Share by Players/Suppliers

Figure 2017 United States Biosimilar Sales Share by Players/Suppliers

Figure United States Biosimilar Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Biosimilar Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Biosimilar Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Biosimilar Revenue Share by Players/Suppliers

Figure 2017 United States Biosimilar Revenue Share by Players/Suppliers

Table United States Market Biosimilar Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)

Figure United States Market Biosimilar Average Price (USD/Unit) of Key Players/Suppliers in 2017

Figure United States Biosimilar Market Share of Top 3 Players/Suppliers

Figure United States Biosimilar Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Biosimilar Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Biosimilar Product Category

Table United States Biosimilar Sales (K Units) by Region (2013-2018)

Table United States Biosimilar Sales Share by Region (2013-2018)

Figure United States Biosimilar Sales Share by Region (2013-2018)

Figure United States Biosimilar Sales Market Share by Region in 2017

Table United States Biosimilar Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Biosimilar Revenue Share by Region (2013-2018)

Figure United States Biosimilar Revenue Market Share by Region (2013-2018)

Figure United States Biosimilar Revenue Market Share by Region in 2017

Table United States Biosimilar Price (USD/Unit) by Region (2013-2018)

Table United States Biosimilar Sales (K Units) by Type (2013-2018)

Table United States Biosimilar Sales Share by Type (2013-2018)

Figure United States Biosimilar Sales Share by Type (2013-2018)

Figure United States Biosimilar Sales Market Share by Type in 2017

Table United States Biosimilar Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Biosimilar Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Biosimilar by Type (2013-2018)

Figure Revenue Market Share of Biosimilar by Type in 2017

Table United States Biosimilar Price (USD/Unit) by Types (2013-2018)

Figure United States Biosimilar Sales Growth Rate by Type (2013-2018)

Table United States Biosimilar Sales (K Units) by Application (2013-2018)

Table United States Biosimilar Sales Market Share by Application (2013-2018)

Figure United States Biosimilar Sales Market Share by Application (2013-2018)

Figure United States Biosimilar Sales Market Share by Application in 2017

Table United States Biosimilar Sales Growth Rate by Application (2013-2018)

Figure United States Biosimilar Sales Growth Rate by Application (2013-2018)

Table Pfizer Basic Information List

Table Pfizer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer Biosimilar Sales Growth Rate (2013-2018)

Figure Pfizer Biosimilar Sales Market Share in United States (2013-2018)

Figure Pfizer Biosimilar Revenue Market Share in United States (2013-2018)

Table Roche Basic Information List

Table Roche Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Roche Biosimilar Sales Growth Rate (2013-2018)

Figure Roche Biosimilar Sales Market Share in United States (2013-2018)

Figure Roche Biosimilar Revenue Market Share in United States (2013-2018)

Table Eli Lilly Basic Information List

Table Eli Lilly Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Eli Lilly Biosimilar Sales Growth Rate (2013-2018)

Figure Eli Lilly Biosimilar Sales Market Share in United States (2013-2018)

Figure Eli Lilly Biosimilar Revenue Market Share in United States (2013-2018)

Table Bayer Basic Information List

Table Bayer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Bayer Biosimilar Sales Growth Rate (2013-2018)

Figure Bayer Biosimilar Sales Market Share in United States (2013-2018)

Figure Bayer Biosimilar Revenue Market Share in United States (2013-2018)

Table Amgen Basic Information List

Table Amgen Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Amgen Biosimilar Sales Growth Rate (2013-2018)

Figure Amgen Biosimilar Sales Market Share in United States (2013-2018)

Figure Amgen Biosimilar Revenue Market Share in United States (2013-2018)

Table Sanofi-Aventis Basic Information List

Table Sanofi-Aventis Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sanofi-Aventis Biosimilar Sales Growth Rate (2013-2018)

Figure Sanofi-Aventis Biosimilar Sales Market Share in United States (2013-2018)

Figure Sanofi-Aventis Biosimilar Revenue Market Share in United States (2013-2018)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Johnson & Johnson Biosimilar Sales Growth Rate (2013-2018)

Figure Johnson & Johnson Biosimilar Sales Market Share in United States (2013-2018)

Figure Johnson & Johnson Biosimilar Revenue Market Share in United States (2013-2018)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Novo Nordisk Biosimilar Sales Growth Rate (2013-2018)

Figure Novo Nordisk Biosimilar Sales Market Share in United States (2013-2018)

Figure Novo Nordisk Biosimilar Revenue Market Share in United States (2013-2018)

Table Merck Basic Information List

Table Merck Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Merck Biosimilar Sales Growth Rate (2013-2018)

Figure Merck Biosimilar Sales Market Share in United States (2013-2018)

Figure Merck Biosimilar Revenue Market Share in United States (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilar

Figure Manufacturing Process Analysis of Biosimilar

Figure Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of Biosimilar Major Players/Suppliers in 2017

Table Major Buyers of Biosimilar

Table Distributors/Traders List

Figure United States Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Biosimilar Price (USD/Unit) Trend Forecast (2018-2025)

Table United States Biosimilar Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Biosimilar Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Biosimilar Sales Volume (K Units) Forecast by Type in 2025

Table United States Biosimilar Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Biosimilar Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Biosimilar Sales Volume (K Units) Forecast by Application in 2025

Table United States Biosimilar Sales Volume (K Units) Forecast by Region (2018-2025)

Table United States Biosimilar Sales Volume Share Forecast by Region (2018-2025)

Figure United States Biosimilar Sales Volume Share Forecast by Region (2018-2025)

Figure United States Biosimilar Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources